TSX News -
Canacol Energy Ltd. Wins Three New Conventional Gas Exploration Blocks in Colombia
CALGARY, Alberta, Dec. 09, 2019 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased […]
TSX News -
Gran Colombia Gold Sets New Monthly Production Record in November 2019; Head Grade at Marmato Improves for Second Consecutive Month
TORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) — Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that it produced […]
TSX News -
Petrus Resources Announces Disposition of Non-Core Assets and Operations Update
CALGARY, Alberta, Dec. 09, 2019 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to […]
Algernon Pharmaceuticals Selects NP-120 (Ifenprodil) for its Lead Phase 2 Trial for Idiopathic Pulmonary Fibrosis and Chronic Cough
VANCOUVER, British Columbia, Dec. 09, 2019 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or […]
MegumaGold Continues to Expand Land Position on Moose River Anticline
HALIFAX, Nova Scotia, Dec. 09, 2019 (GLOBE NEWSWIRE) — MegumaGold Corp. (CSE: NSAU, OTC: NSAUF, FWB: 2CM2) (“MegumaGold” or the […]
TSX News -
Media invitation: Rallying together in support of Publisac
MONTRÉAL, Dec. 08, 2019 (GLOBE NEWSWIRE) — Alliance Forêt Boréale, Ville de Dolbeau-Mistassini, Hebdos Québec, Métro Média as well as […]
TSX News -
Aptose Presents Highlights From Corporate Event At ASH
SAN DIEGO, TORONTO and ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) released […]
Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing […]
Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting
Overview of Clinical Stage XEN901 and Related Patient Survey to be Presented in the “Genetic Epilepsies – Updates in the […]
XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
AUSTIN, Texas, Dec. 07, 2019 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today that it has entered into a […]
